The PI3K-AKT/mTOR pathway has a critical malignant transformation of human tumors [52] and, specifically, is one of the major pathways that is aberrantly activated in ovarian cancer and associated with tumor progression and poor prognosis in patients with ovarian cancer [53]. This evidence concerns the gene MTOR and ovarian cancer.